Lurasidone

INDICATIONS

FDA

  • Schizophrenia in adults and adolescents (age 13-17)
  • Bipolar I depression monotherapy in adults and pediatric patients (age 10-17)
  • Bipolar I depression adjunct therapy to lithium or valproate in adult patients

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: August 23, 2025